Skip to main content
Top

Open Access 25-04-2024 | Telemedicine | Original Paper

The Impact of Telemedicine on Human Immunodeficiency Virus (HIV)-Related Clinical Outcomes During the COVID-19 Pandemic

Authors: Avery Lin Cox, Daniel Tsang, Lisa A. Spacek, Constantine Daskalakis, Dagan Coppock

Published in: AIDS and Behavior

Login to get access

Abstract

The coronavirus disease of 2019 (COVID-19) pandemic exacerbated barriers to care for people living with human immunodeficiency virus (HIV) (PLWH). The quick uptake of telemedicine in the outpatient setting provided promise for care continuity. In this study, we compared appointment and laboratory no-show rates in an urban outpatient HIV clinic during three time periods: (1) Pre-COVID-19: 9/15/2019–3/14/2020 (predominately in-person), (2) “Early” COVID-19: 3/15/2020-9/14/2020 (predominately telemedicine), and (3) “Later” COVID-19: 9/15/2020-3/14/2021 (mixed in-person/telemedicine). Multivariable logistic regression models evaluated the two study hypotheses: (i) equivalence of Period 2 with Period 1 and of Period 3 with Period 1 and (ii) improved outcomes with telemedicine over in-person visits. No-show rates were 1% in Period 1, 4% in Period 2, and 18% in Period 3. Compared to the pre-pandemic period, individuals had a higher rate of appointment no-shows during Period 2 [OR (90% CI): 7.67 (2.68, 21.93)] and 3 [OR (90% CI): 30.91 (12.83 to 75.06). During the total study period, those with telemedicine appointments were less likely to no-show than those with in-person appointments [OR (95% CI): 0.36 (0.16–0.80), p = 0.012]. There was no statistical difference between telemedicine and in-person appointments for laboratory completion rates. Our study failed to prove that no-show rates before and during the pandemic were similar; in fact, no-show rates were higher during both the early and later pandemic. Overall, telemedicine was associated with lower no-show rates compared to in-person appointments. In future pandemics, telemedicine may be a valuable component to maintain care in PLWH.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Merlin JS, et al. Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure. J Acquir Immune Defic Syndr. 2012;61(2):164–70.CrossRefPubMedPubMedCentral Merlin JS, et al. Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure. J Acquir Immune Defic Syndr. 2012;61(2):164–70.CrossRefPubMedPubMedCentral
3.
go back to reference Dombrowski JC, et al. Barriers to HIV care and treatment among participants in a public health HIV care Relinkage program. AIDS Patient Care STDS. 2015;29(5):279–87.CrossRefPubMedPubMedCentral Dombrowski JC, et al. Barriers to HIV care and treatment among participants in a public health HIV care Relinkage program. AIDS Patient Care STDS. 2015;29(5):279–87.CrossRefPubMedPubMedCentral
6.
go back to reference Wood BR, et al. Advancing digital health equity: a policy paper of the infectious diseases society of America and the HIV medicine association. Clin Infect Dis. 2021;72(6):913–9.CrossRefPubMed Wood BR, et al. Advancing digital health equity: a policy paper of the infectious diseases society of America and the HIV medicine association. Clin Infect Dis. 2021;72(6):913–9.CrossRefPubMed
7.
go back to reference El-Nahal WG, et al. Telemedicine and visit completion among people with HIV during the coronavirus disease 2019 pandemic compared with prepandemic. Aids. 2022;36(3):355–62.CrossRefPubMed El-Nahal WG, et al. Telemedicine and visit completion among people with HIV during the coronavirus disease 2019 pandemic compared with prepandemic. Aids. 2022;36(3):355–62.CrossRefPubMed
10.
go back to reference Saberi P. A pilot study to engage and counsel HIV-positive African American youth via telehealth technology. AIDS Patient Care STDs. 2013;27(9):529–32.CrossRefPubMedPubMedCentral Saberi P. A pilot study to engage and counsel HIV-positive African American youth via telehealth technology. AIDS Patient Care STDs. 2013;27(9):529–32.CrossRefPubMedPubMedCentral
11.
go back to reference León A, et al. A new multidisciplinary home care telemedicine system to monitor stable chronic human immunodeficiency virus-infected patients: a randomized study. PLoS ONE. 2011;6(1):e14515.CrossRefPubMedPubMedCentral León A, et al. A new multidisciplinary home care telemedicine system to monitor stable chronic human immunodeficiency virus-infected patients: a randomized study. PLoS ONE. 2011;6(1):e14515.CrossRefPubMedPubMedCentral
12.
go back to reference Ridgway JP, et al. Measuring retention in HIV care in the first year of the COVID-19 pandemic: the impact of telehealth. AIDS Behav. 2023;27(5):1403–8.CrossRefPubMed Ridgway JP, et al. Measuring retention in HIV care in the first year of the COVID-19 pandemic: the impact of telehealth. AIDS Behav. 2023;27(5):1403–8.CrossRefPubMed
13.
go back to reference Czeisler M, et al. Delay or avoidance of medical care because of COVID-19-related concerns - United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(36):1250–7.CrossRefPubMedPubMedCentral Czeisler M, et al. Delay or avoidance of medical care because of COVID-19-related concerns - United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(36):1250–7.CrossRefPubMedPubMedCentral
14.
go back to reference Anderson KE, et al. Reports of forgone medical care among US adults during the initial phase of the COVID-19 pandemic. JAMA Netw Open. 2021;4(1):e2034882–2034882.CrossRefPubMedPubMedCentral Anderson KE, et al. Reports of forgone medical care among US adults during the initial phase of the COVID-19 pandemic. JAMA Netw Open. 2021;4(1):e2034882–2034882.CrossRefPubMedPubMedCentral
15.
go back to reference Toseef MU, et al. Missed appointments during COVID-19: the impact of telehealth for persons experiencing homelessness with substance use disorders. Asian J Psychiatr. 2022;69:102987.CrossRefPubMed Toseef MU, et al. Missed appointments during COVID-19: the impact of telehealth for persons experiencing homelessness with substance use disorders. Asian J Psychiatr. 2022;69:102987.CrossRefPubMed
16.
go back to reference Smith E, Badowski ME. Telemedicine for HIV care: current status and future prospects. Volume 13. HIV AIDS (Auckl); 2021. pp. 651–6. Smith E, Badowski ME. Telemedicine for HIV care: current status and future prospects. Volume 13. HIV AIDS (Auckl); 2021. pp. 651–6.
17.
go back to reference Cooper MP, et al. Impact of the COVID-19 pandemic on hepatitis C outcomes at a health-system specialty pharmacy. J Manag Care Spec Pharm. 2022;28(6):667–72.PubMed Cooper MP, et al. Impact of the COVID-19 pandemic on hepatitis C outcomes at a health-system specialty pharmacy. J Manag Care Spec Pharm. 2022;28(6):667–72.PubMed
18.
go back to reference Baughman D, Zain A, Waheed A. Patient adherence to hemoglobin A1c testing recommendations in telemedicine and in-office cohorts during COVID-19. JAMA Netw Open. 2021;4(9):e2127779–2127779.CrossRefPubMedPubMedCentral Baughman D, Zain A, Waheed A. Patient adherence to hemoglobin A1c testing recommendations in telemedicine and in-office cohorts during COVID-19. JAMA Netw Open. 2021;4(9):e2127779–2127779.CrossRefPubMedPubMedCentral
Metadata
Title
The Impact of Telemedicine on Human Immunodeficiency Virus (HIV)-Related Clinical Outcomes During the COVID-19 Pandemic
Authors
Avery Lin Cox
Daniel Tsang
Lisa A. Spacek
Constantine Daskalakis
Dagan Coppock
Publication date
25-04-2024
Publisher
Springer US
Published in
AIDS and Behavior
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-024-04342-x
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare